« Texas Med Mal Reform | Main | Another Possible Exam Scenario... »
November 28, 2007
FDA Cites Glaxo For Misleading "Dear Doctor" Letters
The FDA has issued a warning letter to GlaxoSmithKline for misleading "Dear Doctor" letters on the drug Tykerb, a daily pill for patients with advanced breast cancer. As CNNMoney (via AP) reports, the FDA asserts that the "Dear Doctor" letters omit the drug's risks and further exaggerate the drug's effectiveness.
- SBS
November 28, 2007 in Current Affairs, Legislation, Reforms, & Political News, Products Liability | Permalink
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/t/trackback/89778/23737208
Listed below are links to weblogs that reference FDA Cites Glaxo For Misleading "Dear Doctor" Letters:
